S
SGMOQ//CIK 0001001233
SANGAMO THERAPEUTICS, INC
Market Data
$0.16+$0.07 (+77.78%)
SGMOQ · Last trade
Prev Close
$0.09
Range (30d)
$0.10 – $0.18
Recent Filings
- 8-K617.7 KBSANGAMO THERAPEUTICS, INCAug 28, 4:05 PM ET·0001193125-26-374328
- SCHEDULE 13G/A10.5 KBSANGAMO THERAPEUTICS, INCAug 14, 10:26 AM ET·0001172661-26-003615
- 8-K176.3 KBSANGAMO THERAPEUTICS, INCAug 12, 9:36 PM ET·0001193125-26-347524
- 8-K3.3 MBSANGAMO THERAPEUTICS, INCAug 12, 4:02 PM ET·0001193125-26-346796
- 8-K139.7 KBSANGAMO THERAPEUTICS, INCJul 20, 4:44 PM ET·0001193125-26-309012
- 8-K143.2 KBSANGAMO THERAPEUTICS, INCJul 1, 4:01 PM ET·0001193125-26-292501
- 8-K/A1.1 MBSANGAMO THERAPEUTICS, INCJun 23, 4:42 PM ET·0001193125-26-279630
- 8-K169.1 KBSANGAMO THERAPEUTICS, INCJun 23, 8:45 AM ET·0001193125-26-278582
- 10-Q4.4 MBSANGAMO THERAPEUTICS, INCMay 14, 4:03 PM ET·0001628280-26-035067
- 8-K301.8 KBSANGAMO THERAPEUTICS, INCMay 14, 4:02 PM ET·0001628280-26-035061
Insiders
10- ANDO DALE GVP, Therapeutic Dev. & CMO
- Beers CourtneyDirector
- BIOGEN INC.10% Owner
- BLUFORD PETERVP, Corporate Development
- Boissel StephaneEVP, Corp. Strategy
- Carey RobertDirector
- CASE CASEY CVP, Research & Operations
- Cleveland Paul BDirector
- Conner Edward R.Sr. VP & Chief Medical Officer
- Davis Gregory DHead of Research & Technology
Tickers
Addresses
business
501 CANAL BLVD.
RICHMOND, CA, 94084
mailing
501 CANAL BLVD.
RICHMOND, CA, 94084
Former Names
- SANGAMO BIOSCIENCES INC2017-01-06